SCHEMBL20844271

SCHEMBL20844271

CC[C@H](C)SN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30358128 1.00
SCHEMBL14293749 1.00
SCHEMBL19629145 0.73
SCHEMBL28080970 0.73
SCHEMBL191109 0.69 TXN (0.38)
SCHEMBL775152 0.69
SCHEMBL20669400 0.69
SCHEMBL5071808 0.69
SCHEMBL26068575 0.67
SCHEMBL290815 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119923397-A Improved process for preparing dimethyl-2, 3-dihydro-1H-indene derivatives 柳韩洋行 2025-05-02 CN claimed
CN-119923397-A Improved process for preparing dimethyl-2, 3-dihydro-1H-indene derivatives 柳韩洋行 2025-05-02 CN disclosed
WO-2023081840-A1 KRAS G12C INHIBITORS FRONTIER MEDICINES CORPORATION (US) 2023-05-11 WO disclosed
US-20190226008-A1 METHODS AND COMPOSITIONS FOR DISCRETE MELT ANALYSIS LUMINEX CORPORATION (US) 2019-07-25 US disclosed
US-20190092851-A1 ANTIBODY MOLECULES TO APRIL AND USES THEREOF Visterra, Inc. 2019-03-28 US disclosed